Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the period ending March 31, 2022. The report details a corporate action approved by the Board of Directors on March 29, 2022, regarding a capital increase resulting from the exercise of stock options under the company's 2017 Stock Option Plan.
Key Financial Metrics
The filing does not provide standard operating financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data presented is specific to the capital increase transaction:
- Capital Increase Amount: BRL 3,685,039.62
- New Capital Stock Total: BRL 58,046,148,653.22
- Shares Issued: 214,122 new common shares (no par value)
- Issuance Price: BRL 17.21 per share
Material Changes
The primary material change is the issuance of 214,122 new common shares. This action increases the company's total capital stock. The filing includes historical market price data for the last three years, two years (quarterly), and six months (monthly), adjusted for dividends and interest on own capital, but does not explicitly highlight material changes in operational performance compared to prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors related to future operations. The document focuses solely on the regulatory notification of the capital increase. The potential dilution from this issuance is noted as minimal:
- Dilution (Number of Shares): 0.001360%
- Dilution (Capital Stock): 0.006349%
Investor Verification Checklist
- Verify the impact of the BRL 3.69 million capital increase on total equity.
- Confirm the minimal dilution effect (0.001360% on share count) on existing shareholders.
- Review the issuance price of BRL 17.21 against the 90-day average market price of BRL 15.03 to understand the premium paid by option holders.
- Note that this filing does not contain quarterly financial results; refer to Form 20-F or other periodic reports for revenue and earnings data.